Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

AVITA Medical (RCEL) Net Margin (2018 - 2025)

AVITA Medical (RCEL) has disclosed Net Margin for 7 consecutive years, with 12.63% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Margin fell 29072.0% year-over-year to 12.63%, compared with a TTM value of 22.84% through Dec 2025, down 2273.0%, and an annual FY2025 reading of 68.55%, down 6844.0% over the prior year.
  • Net Margin was 12.63% for Q4 2025 at AVITA Medical, up from 15.7% in the prior quarter.
  • Across five years, Net Margin topped out at 309.12% in Q4 2022 and bottomed at 168.03% in Q1 2024.
  • Average Net Margin over 4 years is 10.08%, with a median of 69.35% recorded in 2023.
  • Peak annual rise in Net Margin hit 9317bps in 2025, while the deepest fall reached -29072bps in 2025.
  • Year by year, Net Margin stood at 309.12% in 2022, then decreased by -14bps to 265.07% in 2023, then grew by 5bps to 278.09% in 2024, then tumbled by -105bps to 12.63% in 2025.
  • Business Quant data shows Net Margin for RCEL at 12.63% in Q4 2025, 15.7% in Q3 2025, and 54.43% in Q2 2025.